143 related articles for article (PubMed ID: 11885393)
1. Recap of FDA product approvals--2001.
Traynor K
Am J Health Syst Pharm; 2002 Feb; 59(4):321-2, 324. PubMed ID: 11885393
[No Abstract] [Full Text] [Related]
2. Recap of FDA product approvals--2000.
Traynor K
Am J Health Syst Pharm; 2001 Mar; 58(5):363, 366-8. PubMed ID: 11258167
[No Abstract] [Full Text] [Related]
3. Recap of FDA product approvals--1999.
Miller JL
Am J Health Syst Pharm; 2000 Mar; 57(5):418, 421-2. PubMed ID: 10711519
[No Abstract] [Full Text] [Related]
4. Recap of FDA product approvals--2002.
Am J Health Syst Pharm; 2003 Feb; 60(4):310, 312. PubMed ID: 12625212
[No Abstract] [Full Text] [Related]
5. 2020 FDA drug approvals.
Mullard A
Nat Rev Drug Discov; 2021 Feb; 20(2):85-90. PubMed ID: 33402709
[No Abstract] [Full Text] [Related]
6. Antiviral drugs: unapproved uses, dosages, or indications.
Rebora A
Clin Dermatol; 2002; 20(5):474-80. PubMed ID: 12435517
[No Abstract] [Full Text] [Related]
7. Antiviral drugs.
Treat Guidel Med Lett; 2013 Mar; 11(127):19-30. PubMed ID: 23459414
[No Abstract] [Full Text] [Related]
8. FDA perspective on antivirals against biothreats: communicate early and often.
Roberts R; Styrt B; McCune S
Antiviral Res; 2008 Apr; 78(1):60-3. PubMed ID: 18037169
[TBL] [Abstract][Full Text] [Related]
9. New drugs and product approvals from 2001.
Taylor SE
Tex Dent J; 2002 Dec; 119(12):1186-98. PubMed ID: 12592740
[No Abstract] [Full Text] [Related]
10. FDA approves NuvaRing contraceptive implant.
J Gend Specif Med; 2002; 5(2):6. PubMed ID: 11974678
[No Abstract] [Full Text] [Related]
11. FDA recommends hepatitis B drug.
AIDS Patient Care STDS; 2002 Oct; 16(10):511. PubMed ID: 12437861
[No Abstract] [Full Text] [Related]
12. Studying new drugs for HCV. Excerpts from the FDA hearing.
Huff B
GMHC Treat Issues; 2006; 20(8-12):11-4. PubMed ID: 17569164
[No Abstract] [Full Text] [Related]
13. FDA notifications. FDA approves generic foscarnet sodium injection.
AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563
[No Abstract] [Full Text] [Related]
14. Projections on the use of antiviral chemicals in animals.
Gustafson DP
J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1081-4. PubMed ID: 7216876
[No Abstract] [Full Text] [Related]
15. FDA looks at full approval for d4T. Food and Drug Administration.
Posit Aware; 1996; 7(1):7. PubMed ID: 11363131
[TBL] [Abstract][Full Text] [Related]
16. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
DiMasi JA
Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
[TBL] [Abstract][Full Text] [Related]
17. Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs.
Mishra P; Murray J; Birnkrant D
Hepatology; 2015 Oct; 62(4):1298-303. PubMed ID: 25953139
[TBL] [Abstract][Full Text] [Related]
18. New drug approvals in 2002.
Wynn RL
Gen Dent; 2003; 51(3):212-6. PubMed ID: 15055702
[No Abstract] [Full Text] [Related]
19. FDA approves Hep C drugs.
AIDS Alert; 2004 Jun; 19(6):71. PubMed ID: 15272452
[No Abstract] [Full Text] [Related]
20. FDA Approves New Antiviral for Influenza.
Aschenbrenner DS
Am J Nurs; 2019 Feb; 119(2):21. PubMed ID: 30681474
[No Abstract] [Full Text] [Related]
[Next] [New Search]
